Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension-Reference-Cited by-同舟云学术

Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension

Published:2021-11-01 Issue:9 Volume:31 Page:610-622
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Weiss Margaret D.¹^ORCID,Cutler Andrew J.²,Kollins Scott H.³⁴,Donnelly Graeme A.E.⁵

Affiliation:

1. Child and Adolescent Psychiatry, Cambridge Health Alliance, Cambridge, Massachusetts, USA.

2. Department of Psychiatry, Neuroscience Education Institute and SUNY Upstate Medical University, Lakewood Ranch, Florida, USA.

3. Holmusk, Durham, North Carolina, USA.

4. Department of Psychiatry & Behavioral Sciences, Duke University, Durham, North Carolina, USA.

5. Purdue Pharma Canada, Pickering, Ontario, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology and Child Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/cap.2021.0034

Reference40 articles.

1. Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder

2. The Adolescent Outcome of Hyperactive Children Diagnosed by Research Criteria: I. An 8-Year Prospective Follow-up Study

3. Evening circadian preference is associated with sleep problems and daytime sleepiness in adolescents with ADHD

4. SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of sleep disorders in autism spectrum disorder with co-occurring attention-deficit hyperactivity disorder: update for clinicians;BJPsych Open;2023-12-13

2. An updated safety review of the current drugs for managing ADHD in children;Expert Opinion on Drug Safety;2023-10-24

3. Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate;Journal of Attention Disorders;2023-05

4. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD);Cochrane Database of Systematic Reviews;2023-03-27

5. Efficacy and Safety of PRC-063 for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis From Randomized Controlled Trials;Journal of Attention Disorders;2023-02-16